September 16, 2025 · Form 4 insider transaction
GOLDSMITH MARK A sold 13,411 shares of Revolution Medicines, Inc. at $45.82 per share, a transaction worth $614.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Includes 193,475 restricted stock units.